Ngā hua rapu - Christopher J. McDougle
- E whakaatu ana i te 1 - 20 hua o te 71
- Haere ki te Whārangi Whai Ake
-
1
-
2
-
3
-
4
Sertraline and Breast-Feeding mā C. Neill Epperson, George M. Anderson, Christopher J. McDougle
I whakaputaina 1997Carta -
5
Intranasal oxytocin in obsessive-compulsive disorder mā C. Neill Epperson, Christopher J. McDougle, Lawrence H. Price
I whakaputaina 1996Artigo -
6
Developing Drugs for Core Social and Communication Impairment in Autism mā David J. Posey, Craig A. Erickson, Christopher J. McDougle
I whakaputaina 2008Revisão -
7
Psychopharmacological Interventions in Autism Spectrum Disorder mā Laura C. Politte, Charles A. Henry, Christopher J. McDougle
I whakaputaina 2014Revisão -
8
-
9
-
10
-
11
-
12
Antipsychotics in the treatment of autism mā David J. Posey, Kimberly A. Stigler, Craig A. Erickson, Christopher J. McDougle
I whakaputaina 2008Revisão -
13
-
14
-
15
-
16
Sensory Symptoms in Autism Spectrum Disorders mā Eric P. Hazen, Jennifer L. Stornelli, Julia A. O’Rourke, Karmen Koesterer, Christopher J. McDougle
I whakaputaina 2014Revisão -
17
-
18
-
19
A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures mā Laura C. Politte, Lawrence David Scahill, Janet Figueroa, James T. McCracken, Bryan H. King, Christopher J. McDougle
I whakaputaina 2018Artigo -
20
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Psychiatry
Psychology
Autism
Internal medicine
Autism spectrum disorder
Clinical psychology
Schizophrenia (object-oriented programming)
Anxiety
Pediatrics
Risperidone
Irritability
Pathology
Alternative medicine
Biology
Placebo
Developmental psychology
Genetics
Neuroscience
Randomized controlled trial
Adverse effect
Aggression
Environmental health
Pharmacology
Population
Receptor
Attention deficit hyperactivity disorder
Endocrinology
Gene
Pregnancy